Results 7,581-7,600 of 11,246 for speaker:Colm Burke

Special Committee on Covid-19 Response: Examination of HIQA Report on the Impact of Covid-19 on Nursing Homes in Ireland (10 Sep 2020)

Colm Burke: From 1 January 2020-----

Special Committee on Covid-19 Response: Examination of HIQA Report on the Impact of Covid-19 on Nursing Homes in Ireland (10 Sep 2020)

Colm Burke: -----we have no information.

Special Committee on Covid-19 Response: Examination of HIQA Report on the Impact of Covid-19 on Nursing Homes in Ireland (10 Sep 2020)

Colm Burke: Why was it excluded? Why not include it in the information? The report that HIQA published, and even the presentation earlier, referred to what occurred since 13 March. We are anxious to find out what level of engagement there was with nursing homes between the time this issue emerged in Europe and 13 March. We have no information and it has not been presented to us at any stage. I...

Special Committee on Covid-19 Response: Examination of HIQA Report on the Impact of Covid-19 on Nursing Homes in Ireland (10 Sep 2020)

Colm Burke: Was there communication with the HSE?

Special Committee on Covid-19 Response: Examination of HIQA Report on the Impact of Covid-19 on Nursing Homes in Ireland (10 Sep 2020)

Colm Burke: What was the HSE's response?

Special Committee on Covid-19 Response: Examination of HIQA Report on the Impact of Covid-19 on Nursing Homes in Ireland (10 Sep 2020)

Colm Burke: Ms Dunnion might recall that at that period, there was a considerable effort by the HSE to move people out of hospitals. Does Ms Dunnion agree that people were transferred out of hospitals to these facilities?

Special Committee on Covid-19 Response: Examination of HIQA Report on the Impact of Covid-19 on Nursing Homes in Ireland (10 Sep 2020)

Colm Burke: I am aware of that, but is HIQA aware of people being transferred out of hospitals into facilities that it highlighted to the HSE as being at risk? Were people transferred to those facilities between 1 February 2020 and the time when the outbreaks started occurring?

Special Committee on Covid-19 Response: Examination of HIQA Report on the Impact of Covid-19 on Nursing Homes in Ireland (10 Sep 2020)

Colm Burke: Of the nursing homes that Ms Dunnion stated were under the HSE's control and were not complying with the regulations, how many were identified where patients were transferred to? To put the matter in context, such nursing homes were on the early warning list so surely to God HIQA would have checked what number of patients were being transferred to those facilities. We can look at our...

Special Committee on Covid-19 Response: Examination of HIQA Report on the Impact of Covid-19 on Nursing Homes in Ireland (10 Sep 2020)

Colm Burke: Can I get answers in writing to the specific questions I have asked?

Special Committee on Covid-19 Response: Examination of HIQA Report on the Impact of Covid-19 on Nursing Homes in Ireland (10 Sep 2020)

Colm Burke: I will return to the assessment framework that was issued on 21 April. If HIQA was planning to deal with this matter as far back as January 2020, why did it take until 21 April? At that stage, there were 194 clusters in nursing homes. Why did HIQA wait until 21 April to send that to nursing homes? How come it was not sent out at an earlier stage? We were then at a stage when 194 clusters...

Special Committee on Covid-19 Response: Examination of HIQA Report on the Impact of Covid-19 on Nursing Homes in Ireland (10 Sep 2020)

Colm Burke: Does Ms Dunnion believe that if there was more engagement with private nursing homes by the HSE, HIQA and all the other statutory agencies, many more of the outbreaks that occurred could have been prevented?

Special Committee on Covid-19 Response: Examination of HIQA Report on the Impact of Covid-19 on Nursing Homes in Ireland (10 Sep 2020)

Colm Burke: Does Ms Dunnion accept that HIQA and the HSE should have engaged with private nursing homes? There was engagement with hospitals and publicly-run nursing homes, but engagement with private nursing homes seems to have been put on the back-burner.

Special Committee on Covid-19 Response: Examination of HIQA Report on the Impact of Covid-19 on Nursing Homes in Ireland (10 Sep 2020)

Colm Burke: We have seen none of that engagement or communication from 1 January 2020 until 21 April. HIQA confirmed in its report that from 25 March onwards, there were more than 2,500 phone calls but we have no information about what occurred in the preceding three and a half months.

Written Answers — Department of Justice and Equality: Citizenship Applications (9 Sep 2020)

Colm Burke: 243. To ask the Tánaiste and Minister for Justice and Equality if an application for citizenship by a person (details supplied) will be progressed to decision stage; and if she will make a statement on the matter. [22843/20]

Written Answers — Department of Health: Medicinal Products (9 Sep 2020)

Colm Burke: 275. To ask the Minister for Health the date his Department received the final report by a company (details supplied) into its independent external review of the HSE medicine reimbursement process; if he will provide an overview of the findings and recommendations of the report; when it is expected to be submitted to him; and if he will make a statement on the matter. [22867/20]

Written Answers — Department of Health: Medicinal Products (9 Sep 2020)

Colm Burke: 276. To ask the Minister for Health the medicines submitted to HSE leadership or executive management team for reimbursement approval; the date of each meeting; the outcome of each meeting from 1 January 2019 to date; and if he will make a statement on the matter. [22868/20]

Written Answers — Department of Health: Rare Diseases Strategy (9 Sep 2020)

Colm Burke: 277. To ask the Minister for Health his plans to publish an updated national rare disease plan as per the Programme for Government; when he expects to publish the plan; and if he will make a statement on the matter. [22870/20]

Written Answers — Department of Health: Rare Diseases Strategy (9 Sep 2020)

Colm Burke: 279. To ask the Minister for Health the status of the work of the rare diseases technology review committee of the HSE; the meetings it has held to date in 2020, in tabular form; the meetings and therapies it has scheduled for the remainder of 2020; and if he will make a statement on the matter. [22873/20]

Written Answers — Department of Health: Medicinal Products (9 Sep 2020)

Colm Burke: 280. To ask the Minister for Health the status of the reimbursement of the drug osimertinib for lung cancer in a first line setting; and if he will make a statement on the matter. [22874/20]

Special Committee on Covid-19 Response: Covid-19: Legislative Framework Underpinning the State's Response (9 Sep 2020)

Colm Burke: I thank the witnesses for their presentations and for the time they are giving to us this morning. It is very much appreciated. I want to go back to the issue of co-ordination across Europe and in the UK. Do the witnesses feel that there could have been far more co-operation among member states on having a coherent set of regulations across Europe rather than individual states taking this...